Aspen Biopharma Labs Pvt., Ltd. FDA Record
- Latest inspection OAI · Sep 21, 2024
- Last warning letter 2025
Aspen Biopharma Labs Pvt., Ltd. has 6 FDA recalls, 1 inspection, 0 510(k) clearances and 1 compliance action on record. FDA has issued 1 warning letter to Aspen Biopharma Labs Pvt., Ltd., the most recent on Mar 5, 2025.
- Latest recall
- D-0263-2025 · Class II · Feb 7, 2025
- Latest inspection
- Sep 21, 2024 · OAI
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 6 | Nov 15, 2026 | File dated Nov 10, 2026 | Current |
| 510(k) clearances | 0 | Nov 15, 2026 | File dated Nov 9, 2026 | Current |
| Inspections | 1 | Nov 17, 2026 | Newest record Nov 9, 2026 | Current |
| Compliance actions | 1 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
FDA record by year
Aspen Biopharma Labs Pvt., Ltd.: FDA inspections per year
| Year | Inspections | OAI | Warning letters | Recall records | Class I |
|---|---|---|---|---|---|
| 2026 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 1 | 6 | 0 |
| 2024 | 1 | 1 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 0 | 0 | 0 |
| 2019 | 0 | 0 | 0 | 0 | 0 |
| 2018 | 0 | 0 | 0 | 0 | 0 |
| 2017 | 0 | 0 | 0 | 0 | 0 |
Reviewing Aspen Biopharma Labs Pvt., Ltd. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Aspen Biopharma Labs Pvt., Ltd. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Aspen Biopharma Labs Pvt., Ltd. FDA Warning Letters
| Issued | Subject | Issuing office | Close-out letter |
|---|---|---|---|
| Mar 5, 2025 · Record page |
Recent recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0263-2025 | Class II | Chlorambucil Container Description: The product packed in double self-seal cover and finally packed… | Feb 7, 2025 |
| D-0264-2025 | Class II | Latanoprost NDC# 82187-1002-1 Container Description: Amber colour bottle | Feb 7, 2025 |
| D-0260-2025 | Class II | Bimatoprost NDC# 82187-1001-1 Container description: The product packed in double self-seal cover… | Feb 7, 2025 |
| D-0262-2025 | Class II | Finasteride NDC# 82187-1003-1 Container Description: The product packed in white poly bag… | Feb 7, 2025 |
| D-0265-2025 | Class II | Voriconazole Container Description: voriconazole The product packed in white poly bag containing… | Feb 7, 2025 |
| D-0261-2025 | Class II | Alprostadil Container Description: Amber color bottle | Feb 7, 2025 |
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Sep 21, 2024 | Medchal Malkajgiri, India | Drugs | Official Action Indicated (OAI) | 3012796281 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
Compliance Actions
FDA's compliance actions data lists 1 compliance action under Aspen Biopharma Labs Pvt., Ltd.: warning letters, injunctions and seizures. None came from FDA's Center for Tobacco Products.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 3012796281 | Medchal Malkajgiri, India | 1 | Sep 21, 2024 |
Aspen Biopharma Labs Pvt., Ltd. and the FDA: common questions
Has Aspen Biopharma Labs Pvt., Ltd. received an FDA warning letter?
Yes. FDA has issued 1 warning letter to Aspen Biopharma Labs Pvt., Ltd.. The most recent is dated Mar 5, 2025.
Has Aspen Biopharma Labs Pvt., Ltd. received an FDA Form 483?
FDA has not published a Form 483 for "Aspen Biopharma Labs Pvt., Ltd." in its reading room. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect Aspen Biopharma Labs Pvt., Ltd.?
The most recent FDA inspection on file ended Sep 21, 2024 at Medchal Malkajgiri, India and was classified OAI. FDA has 1 inspection of Aspen Biopharma Labs Pvt., Ltd. on file, 1 of them classified OAI (official action indicated).
Has Aspen Biopharma Labs Pvt., Ltd. had an FDA recall?
Yes. Aspen Biopharma Labs Pvt., Ltd. has 6 FDA recalls on record. The most recent started Feb 7, 2025.
Need more than this page shows? Ask about Aspen Biopharma Labs Pvt., Ltd. in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.